We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App




Electrosurgery Procedure Recanalizes Stenoses

By HospiMedica staff writers
Posted on 15 Nov 2000
A new treatment for stenoses of the central respiratory tract that is safe and offers few complications is electrosurgery applied by means of a rigid or flexible bronchoscope. More...
A flexible scope offers more surgical freedom and gives the surgeon access to individual bronchopulmonary lobular segments. However, a rigid scope would be more appropriate for the retrieval of large volumes of blood or tissue or for the introduction of larger instruments.

Stenoses of the central respiratory tract are usually caused by benign or malignant tumors. To recanalize such stenoses, a procedure called Argon-Plasma Coagulation (APC) is employed in interventional bronchoscopy to destroy, coagulate, or reduce and excise pathologic tissue using high-frequency current. Instruments transmit this electric current via ionized argon gas in a noncontact process to the tissue. Compared to other interventional procedures, APC achieves an immediate shrinkage of the stenoses, bringing under control a respiratory condition that may be acute and threatening. APC has been successfully used for open surgery, gastroenterology, and ear-nose-throat applications.

APC comprises an electrosurgical unit (ERBOTOM ICC 350), the plasma coagulation unit (ERBE APC 300), and tracheobronchial probes and applicators. The system is the product of ERBE Elektromedizin GmbH (Tubingen, Germany). ERBE states that the APC procedure is largely free of carbonization and vaporization, with reduced release of aerosols. Since the penetration depth is limited, the risk of injury to adjacent structures is minimized and virtually precludes any risk of perforation.



Related Links:
www.erbe-med.com

Gold Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Floor‑Mounted Digital X‑Ray System
MasteRad MX30+
Mammography System (Analog)
MAM VENUS
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.